Expression and purification of Mycobacterium tuberculosis F₄₂₀-dependent glucose-6-phosphate dehydrogenase enzyme...

Since their discovery in Mycobacterium tuberculosis (Mtb), F₄₂₀-dependent enzymes have been identified as both important drug targets and potential industrial biocatalysts, including for bioremediation of otherwise recalcitrant substrates. Mtb-FGD1, utilizes glucose 6-phosphate (G6P) as an electron donor for the reduction of F₄₂₀. Current expression systems for Mtb-FGD1 use Mycobacterium smegmatis as host, because of the tendency for it to form inclusion bodies in E. coli. However, large scale recombinant protein production using M. smegmatis is slow and costly and the organism is not generally recognized as safe. Here, we report a faster, cheaper and safer approach for the expression of fully functional Mtb-FGD1 in E. coli using cold-adapted GroEL/ES as chaperones. Our approach yielded ∼70 mg of protein per litre (L) of culture. The purified enzyme catalysed the reduction of F₄₂₀ to F₄₂₀.H₂ in the presence of G6P, and the re-oxidation of the F₄₂₀.H₂ to F₄₂₀ when coupled to Tfu-FNO, which is a thermostable oxidoreductase that utilizes F₄₂₀ for the reversible oxidation of NADPH. This latter finding provides opportunity for the utilization of Mtb-FGD1 as an industrial biocatalyst or in the detoxification of environmental contaminants such as malachite green, picrate and aflatoxin.